in Total Papers Downloads
in Total Papers Citations
class actions, expert testimony, aggregate proof, fraud-on-the-market doctrine, civil RICO, tobacco litigation, Wal-Mart, employment discrimination, pattern or practice of discrimination
Arbitration, Arbitration Fairness Act, Class Action, Class Arbitration, Concepcion, Erie Doctrine, Extraterritoriality, Federal Arbitration Act, Hanna Doctrine, Rules Enabling Act, Shady Grove, Stolt-Nielsen, Transnational Judgment Recognition
class actions, aggregate litigation, group litigation, Royal Dutch Shell settlement, Vivendi securities litigation, preclusion, arbitration, CAFA, comparative procedure, American exceptionalism, European civil procedure
Adequate representation, CAFA, Class Action Fairness Act, class actions, class settlements, collateral attacks, due process
aggregate proof, antitrust, class action, class certification, Dukes, employment discrimination, fraud on the market, pattern or practice of discrimination, proximate cause, RICO, securities fraud, sex discrimination, Title VII, Wal-Mart
aggregate litigation, aggregate settlement rule, class actions, Freedom of Information Act, punitive damages, Vioxx
class actions, class certification, cost of litigation, Daubert, discovery, Iqbal, pleading, summary judgment, Twombly, variance
Amchem, bootstrapping, CAFA, choice of law, Class Action Fairness Act, class actions, conflicts of law, diversity jurisdiction, due process, Erie, Klaxon, preexistence principle, removal, Shutts
Class Actions, CAFA, Settlement, Class Settlement Pressure, Class-Wide Arbitration, Choice of Law, Aggregation, Litigation
administrative state, Class Action Fairness Act, class actions, due process, positive political theory, settlement, Wal-Mart
Attorneys fees, contingency fees, principal-agent, allocation, class actions, aggregate settlements
CAFA, class counsel, class actions, attorneys' fees, gatekeeping, incentive awards, Milberg Weiss, PSLRA, rent extraction, restitution
administrative law, antidepressants, Chevron, drugs, FDA, labeling, medical devices, pharmaceuticals, preference revealing, preemption, products liability, SSRIs, tort law
Cookies are used by this site. To decline or learn more, visit our Cookies page.
This page was processed by apollobot1 in 0.390 seconds
We'd like to ask you to provide feedback on your experience with SSRN today. Your feedback will be used to enhance the site in the future.
Would you be willing to answer a few questions when you leave our site?
Yes, I'm willing to take part in a survey
No, thank you